Insmed Inc reports results for the quarter ended June 30 - Earnings Summary

• Insmed Inc INSM reported a quarterly adjusted loss of $1.70​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.94. The mean expectation of sixteen analysts for the quarter was for a loss of $1.29 per share. Wall Street expected results to range from $-1.46 to $-1.20 per share.

• Revenue rose 18.9% to $107.42 million from a year ago; analysts expected $103.82 million.

• Insmed Inc's reported EPS for the quarter was a loss of $1.70​.

• The company reported a quarterly loss of $321.69 million.

• Insmed Inc shares had risen by 10.6% this quarter and gained 61.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.5% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Insmed Inc is $112.00, about 0.7% above its last closing price of $111.26

This summary was machine generated from LSEG data August 7 at 04:17 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)